InMode (INMD) Total Liabilities (2018 - 2026)
InMode (INMD) posted quarterly Total Liabilities of $89.6 million for Q1 2026, up 5.01% year-on-year from $85.3 million in Q1 2025, and up 7.63% on a QoQ basis from $83.2 million in Q4 2025.
InMode (INMD) Total Liabilities (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Total Liabilities for 9 consecutive years, with $89.6 million the latest figure, recorded in Q1 2026.
- Quarterly Total Liabilities rose 5.01% year-over-year to $89.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.6 million (up 5.01% YoY) and the FY2025 annual result came in at $83.2 million, up 1.68% from the prior year.
- Total Liabilities advanced to $89.6 million in Q1 2026 per INMD's latest filing, from $83.2 million in the prior quarter.
- Over the last five years, Total Liabilities for INMD reached as high as $108.7 million in Q2 2024 and fell as low as $61.1 million in Q1 2022.
- A 5-year average of $79.2 million and a median of $79.9 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities soared 60.05% — and 2025, when it retreated 26.49%.
- Year by year, Total Liabilities stood at $89.8 million in 2022, then decreased by 15.45% to $75.9 million in 2023, then climbed by 7.82% to $81.9 million in 2024, then climbed by 1.68% to $83.2 million in 2025, then climbed by 7.63% to $89.6 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $89.6 million, $83.2 million, and $81.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 89.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.58 Mn |
| Dec 31, 2025 | 83.23 Mn |
| Sep 30, 2025 | 81.22 Mn |
| Jun 30, 2025 | 79.91 Mn |
| Mar 31, 2025 | 85.31 Mn |
| Dec 31, 2024 | 81.85 Mn |
| Sep 30, 2024 | 87.14 Mn |
| Jun 30, 2024 | 108.72 Mn |
| Mar 31, 2024 | 76.30 Mn |
| Dec 31, 2023 | 75.91 Mn |
| Sep 30, 2023 | 70.03 Mn |
| Jun 30, 2023 | 67.93 Mn |
| Mar 31, 2023 | 66.63 Mn |
| Dec 31, 2022 | 89.79 Mn |
| Sep 30, 2022 | 70.68 Mn |
| Jun 30, 2022 | 70.39 Mn |
| Mar 31, 2022 | 61.15 Mn |
| Dec 31, 2021 | 62.74 Mn |
| Sep 30, 2021 | 63.63 Mn |
| Jun 30, 2021 | 51.86 Mn |